An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The 2 × 2 crossover designed study is to evaluate the bioequivalence of two different
liposomal amphotericin B injections after single IV infusion at the same dose in normal
healthy subjects.